278 related articles for article (PubMed ID: 7862883)
1. Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release.
Spanagel R; Almeida OF; Bartl C; Shippenberg TS
Psychopharmacology (Berl); 1994 Jun; 115(1-2):121-7. PubMed ID: 7862883
[TBL] [Abstract][Full Text] [Related]
2. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
Sinchaisuk S; Ho IK; Rockhold RW
Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
[TBL] [Abstract][Full Text] [Related]
3. Direct evidence for the involvement of the mesolimbic kappa-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state.
Narita M; Kishimoto Y; Ise Y; Yajima Y; Misawa K; Suzuki T
Neuropsychopharmacology; 2005 Jan; 30(1):111-8. PubMed ID: 15257306
[TBL] [Abstract][Full Text] [Related]
4. Modulation of morphine-induced sensitization by endogenous kappa opioid systems in the rat.
Spanagel R; Shippenberg TS
Neurosci Lett; 1993 Apr; 153(2):232-6. PubMed ID: 8392157
[TBL] [Abstract][Full Text] [Related]
5. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
Stinus L; Cador M; Zorrilla EP; Koob GF
Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
[TBL] [Abstract][Full Text] [Related]
6. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
Crain SM; Shen KF
Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
[TBL] [Abstract][Full Text] [Related]
7. The kappa-opioid receptor antagonist, nor-binaltorphimine (nor-BNI), decreases morphine withdrawal and the consequent conditioned place aversion in rats.
Kelsey JE; Verhaak AM; Schierberl KC
Behav Brain Res; 2015 Apr; 283():16-21. PubMed ID: 25591478
[TBL] [Abstract][Full Text] [Related]
8. Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal.
Chartoff EH; Mague SD; Barhight MF; Smith AM; Carlezon WA
J Neurosci; 2006 Jun; 26(24):6450-7. PubMed ID: 16775132
[TBL] [Abstract][Full Text] [Related]
9. Anatomically dissociable effects of dopamine D1 receptor agonists on reward and relief of withdrawal in morphine-dependent rats.
Chartoff EH; Barhight MF; Mague SD; Sawyer AM; Carlezon WA
Psychopharmacology (Berl); 2009 Jun; 204(2):227-39. PubMed ID: 19148621
[TBL] [Abstract][Full Text] [Related]
10. Increase of extracellular dopamine in the medial prefrontal cortex during spontaneous and naloxone-precipitated opiate abstinence.
Bassareo V; Tanda G; Di Chiara G
Psychopharmacology (Berl); 1995 Nov; 122(2):202-5. PubMed ID: 8848538
[TBL] [Abstract][Full Text] [Related]
11. Blockade of morphine reward through the activation of kappa-opioid receptors in mice.
Funada M; Suzuki T; Narita M; Misawa M; Nagase H
Neuropharmacology; 1993 Dec; 32(12):1315-23. PubMed ID: 7908722
[TBL] [Abstract][Full Text] [Related]
12. Nor-binaltorphimine precipitates withdrawal and excitatory amino acid release in the locus ceruleus of butorphanol--but not morphine-dependent rats.
Feng Y; Rockhold RW; Ho IK
J Pharmacol Exp Ther; 1997 Nov; 283(2):932-8. PubMed ID: 9353416
[TBL] [Abstract][Full Text] [Related]
13. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M
Jpn J Pharmacol; 2002 Apr; 88(4):399-406. PubMed ID: 12046982
[TBL] [Abstract][Full Text] [Related]
14. Long-term opiate effects on amphetamine-induced dopamine release in the nucleus accumbens core and conditioned place preference.
He S; Li N; Grasing K
Pharmacol Biochem Behav; 2004 Feb; 77(2):327-35. PubMed ID: 14751461
[TBL] [Abstract][Full Text] [Related]
15. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal.
Azar MR; Jones BC; Schulteis G
Psychopharmacology (Berl); 2003 Oct; 170(1):42-50. PubMed ID: 12783156
[TBL] [Abstract][Full Text] [Related]
16. Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.
Schulteis G; Morse AC; Liu J
Psychopharmacology (Berl); 2004 Oct; 175(4):463-72. PubMed ID: 15083263
[TBL] [Abstract][Full Text] [Related]
17. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
Cavun S; Göktalay G; Millington WR
J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
[TBL] [Abstract][Full Text] [Related]
18. The glial activation inhibitor AV411 reduces morphine-induced nucleus accumbens dopamine release.
Bland ST; Hutchinson MR; Maier SF; Watkins LR; Johnson KW
Brain Behav Immun; 2009 May; 23(4):492-7. PubMed ID: 19486648
[TBL] [Abstract][Full Text] [Related]
19. [Involvement of the amygdala on place aversion induced by naloxone in single-dose morphine-treated rats].
Ishida S; Shimosaka R; Kawasaki Y; Jin C; Kitamura Y; Araki H; Sendo T; Gomita Y
Yakugaku Zasshi; 2008 Mar; 128(3):395-403. PubMed ID: 18311059
[TBL] [Abstract][Full Text] [Related]
20. Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal.
Diana M; Muntoni AL; Pistis M; Melis M; Gessa GL
Eur J Neurosci; 1999 Mar; 11(3):1037-41. PubMed ID: 10103095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
